• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Omrix Biopharmaceuticals

Omrix Biopharmaceuticals

  1. Igenbio and Genome Compiler Corp. Enter into a Collaborative Agreement to Offer Synthetic Biology Solutions

    Igenbio and Genome Compiler Corp. Enter into a Collaborative Agreement to Offer Synthetic Biology Solutions

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.